Wells Fargo Raises Welltower (WELL) Price Target to $268

Wells Fargo reaffirmed its positive stance on Welltower Inc. WELL on October 19, 2026, keeping an Overweight rating on the shares while nudging its price target higher. The research note from Wells Fargo moved the target from $266.0 to $268.0 as the healthcare property owner continued through the autumn trading schedule. Welltower closed at $233.51 on the day of the update.

WELL Welltower Inc.

$233.54 ▲ +26.27% year to date

1M 3M YTD

Daily close · Oct 19, 2026

Wells Fargo's Call on Welltower Inc.

In its October 19, 2026 research note, Wells Fargo maintained its Overweight rating on Welltower Inc. and ticked its price target up from the previous level of $266.0 to $268.0. An Overweight rating is a forward-looking opinion that the firm expects the stock to do better than the average market return or its industry peers. The updated target of $268.0 marks a modest bump for the real estate investment trust as analysts review performance across the healthcare housing sector.

Other Institutional Activity in Welltower Inc.

Large financial firms continue to adjust their holdings in the healthcare property company. Capital International Investors held 39,500,055 shares worth about $9,223,657,626 after growing its stake by 3,682,087 shares, representing a 10.3% increase in its report for the quarter ended June 30, 2026. Cohen & Steers Inc. grew its holdings by 975,018 shares, ending with 36,821,274 shares worth about $8,598,135,489 following a 2.7% increase. PFG Advisors reported a stake of 6,534 shares valued at about $1,504,388.

Welltower Inc. Stock Down 0.6%

Welltower recently traded around $233.51 as of October 20, 2026, remaining roughly equal to its price on the day of the Wells Fargo update. The shares trade well above their 200-day moving average of $216.33, though they sit below the 52-week high of $255.20.

Recent Earnings

Welltower posted trailing-twelve-month revenue of $12,763,214,848 alongside basic trailing earnings of $2.23 per share. The company has a return on equity of 3.8% and a net profit margin of 12.1%, with its next earnings report scheduled for October 26, 2026.

Dividend

The company pays an annual dividend rate of $3.40 per share, offering a dividend yield of 1.46% with a payout ratio of 132.7%.

Insider Buying and Selling at Welltower Inc.

Company insiders have made notable transactions over recent quarters. Director Andrew Gundlach bought 20,000 shares at an average price of $151.46 on June 30, 2025, for a total value of $3,029,200. Gundlach later bought another 10,000 shares on August 26, 2026.

Analysts Set New Price Targets

Wall Street firms have actively updated their views on Welltower in recent weeks. Scotiabank maintained a Sector Outperform rating while raising its target to $251.0 from $244.0 on September 2, 2026. Evercore ISI Group maintained an Outperform rating while adjusting its target from $260.0 to $256.0 on September 21, 2026. JP Morgan upgraded the stock to Overweight with a $260.0 target on September 24, 2026. Barclays maintained an Equal-Weight rating and lowered its target from $259.0 to $246.0 on October 13, 2026. Overall, the stock carries a consensus buy rating across 22 analyst opinions.

About Welltower Inc.

Welltower Inc. operates as a real estate investment trust focused on the healthcare sector, specifically senior housing and wellness properties across the United States, Canada, and the United Kingdom. The company manages properties designed to meet the housing needs of aging populations, connecting real estate with senior care operations.

Bottom Line

Wells Fargo's updated price target offers another data point for investors to consider ahead of Welltower's upcoming earnings release on October 26, 2026. Analyst price targets reflect forward-looking expectations and do not guarantee future stock performance.